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Midterm outcome of endovascular abdominal
aortic aneurysm repair in octogenarians: A single
institution’s experience
M. Biebl, MD,a L. L. Lau, MD,a A. G. Hakaim, MD,a W. A. Oldenburg, MD,a J. Klocker, MD,a B.
Neuhauser, MD,a J. M. McKinney, MD,b and R. Paz-Fumagalli, MD,b Jacksonville, Fla
Objectives: We analyzed midterm durability of endovascular abdominal aortic aneurysm repair (EVAR) in octogenarians
compared with younger patients.
Methods: Data for 182 consecutive patients who underwent elective EVAR between 1999 and 2003 were retrospectively
reviewed. Forty-nine patients (27%) were 80 years or older (study group [SG]; mean age, 84 years; range, 80-89 years),
and 133 patients (73%) were younger (control group [CG]; mean age, 72 years; range, 53-79 years). 2 analysis, Fisher
exact test, Student t test, and Mann-Whitney U test were used as appropriate to test for intergroup differences.
Kaplan-Meier curves, log-rank tests, and multivariate Cox models were used for time-to-event analysis, with P < .05
considered significant.
Results: Mean follow-up was 16 months (range, 1-43 months). Body weight was higher (P < .001), and elevated plasma
lipid levels (59% vs 43%; P  .042) and use of nicotine (47% vs 29%; P  .015) more frequent in the octogenarians.
Baseline aneurysm size, procedure-related data, and hospital stay were comparable between groups. Aneurysm-related
mortality was 0% in the study group and 0.7% in the control group (P  .740). Systemic complications occurred in 22%
(SG) versus 11% (CG) (P  .035), owing to a rise in serum creatinine concentration greater than 30% of baseline in 14%
in the octogenarian group (vs 5% in the CG; P  .048). Groin lymphoceles developed in 12% (SG) versus 2% (CG; P 
.013). Technical success was 96% (SG) versus 98% (CG; P  .408), and clinical success was 86% versus 90% (P  .269).
No aneurysm rupture occurred during follow-up, and aneurysm-related adverse events were comparable between groups.
The estimated risk for any type of endoleak (2.2; 95% confidence interval [CI], 1.1-4.2; P  .023) or type II endoleak
(2.1; 95% CI, 1.0-4.3; P  0.51) was higher in the study group versus the control group; however, this did not affect
secondary procedure rates (SG 16% vs CG 12%; estimated risk, SG vs CG,: 1.5; 95% CI, 0.6-3.6; P 0.420) or aneurysm
remodeling (97.2% combined aneurysm sac stabilization or decrease in both groups; P  .592). Aneurysm enlargement
occurred in 2.8% (SG 1 vs CG 4; P  .592).
Conclusion: Elective EVAR in octogenarians appears safe and effective over midterm follow-up, with a temporary decrease
in renal function (14%) and postoperative lymphoceles (12%) being the most common postoperative adverse events.
Advanced chronologic age is not associated with diminished procedural outcome, clinical success, or postoperative
survival, compared with younger age. Because of low perioperative mortality and high procedural success, EVAR may be
the preferred approach to abdominal aortic aneurysm treatment in selected elderly patients. (J Vasc Surg 2004;40:
435-42.)Steadily increasing over the past decades, the current
mean life expectancy in the United States is 76.9 years.
With this lengthened life span, more elderly, who have
become the fastest growing population segment in the
United States,1 will require surgical care. Ultrasound
screening studies have revealed an overall prevalence of
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doi:10.1016/j.jvs.2004.05.021abdominal aortic aneurysms (AAA) of about 5% in men,2
with percentages rising from 1% at age 55 to 60 years to
10% in patients 80 years of age or older.3 In addition, AAAs
in octogenarians appear to be more prone to rupture than
in patients younger than 80 years.4-6 Before the era of
endovascular aneurysm repair (EVAR) elderly patients were
more likely to be denied surgical AAA repair,7 because of
the frequent presence of multiple comorbid conditions.
Ample evidence, however, suggests that surgically treated
octogenarians have a significantly greater life expectancy
than those with untreated AAAs.8,9 Nevertheless, periop-
erative mortality and morbidity after open aortic surgery
remained higher compared with that in younger patients.10
The introduction of EVAR has considerably changed the
balance of risks and benefits for AAA treatment,11 and
recent large studies have documented feasibility and effi-
cacy in patients previously considered unfit for open repair.
Morbidity and mortality rates for EVAR in octogenarians
have proved acceptable and comparable with open sur-435
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et al14 identified age older than 70 years alone as an
independent risk factor for perioperative complications
after EVAR.
The purpose of this study was to report our experience
with EVAR in octogenarian patients and to compare the
outcome with that in younger patients.
PATIENTS AND METHODS
All EVAR procedures performed at the Mayo Clinic,
Jacksonville, Fla, were retrospectively reviewed for this
study. Patient survival, freedom from secondary proce-
dures, and freedom from endoleak were considered pri-
mary study end points. Secondary end points were postop-
erative complications, technical and clinical success,
freedom from type II endoleak, and aneurysm sac remod-
eling. Data were extracted from patient records and our
computerized endovascular database, which contains infor-
mation including patient demographic data, comorbid
conditions, perioperative parameters, and follow-up data.
EVAR was offered to all patients with aortoiliac aneu-
rysm disease who were considered at high risk for open
surgery in the presence of amenable aortoiliac anatomy or
when the patient favored EVAR over open repair. Preop-
erative aortic measurements were obtained with computed
tomography (CT) angiography with 3-mm collimation and
multiple 3-dimensional reconstructions. Circumferential
calcification of narrow iliac arteries (7-mm diameter),
proximal aneurysm necks with mural thrombus or inverted
funnel shape (10% increase in diameter over 15 mm of
length), or proximal neck angulation greater than 60 de-
grees were considered anatomic exclusion criteria. A prox-
imal neck diameter 32 mm or smaller was acceptable for the
Talent device, 30 mm or smaller for custom-made en-
dografts, 28 mm or smaller for the Zenith device, and
smaller than 25 mm for infrarenally anchored endografts.
These anatomic exclusion criteria were used for all patients
during the study period, irrespective of age.
Twenty-three patients (12.6%) received a custom-made
aortomonoiliac device with femorofemoral crossover by-
pass as part of an investigational device exemption (IDE)
trial for patients at high surgical risk. Other devices used
included 87 (47.8%) AneuRx (Medtronic AVE), 40
(22.0%) Zenith (Cook), 18 (9.9%) Talent (Medtronic), 12
(6.6%) Ancure (Guidant), and 2 (1.1%) Excluder (W. L.
Gore and Associates) endografts.
Follow-up adhered to a standardized surveillance pro-
tocol that included physical examination, biplanar abdom-
inal plain radiography, and helical CT angiography at 1, 6,
and 12 months post procedure and every 6 to 12 months
thereafter.
Endoleak. Endoleaks demonstrated on CT scans
within 40 days after device implantation were classified as
early, and all others as late endoleaks. For analysis of time to
occurrence of endoleak, all patients with evidence of an
endoleak at CT follow-up were counted as positive for
endoleak, irrespective of whether the endoleak persisted,
was treated, or resolved later during follow-up. All type I(perigraft) and type III (transgraft) endoleaks were treated
immediately, whereas type II (branch vessel) endoleaks
were observed unless the maximum transverse aneurysm
diameter increased by 5 mm or more or the patient had
pain.
Endograft migration was defined as caudal dislocation
of the endograft of 10 mm or more. Migration, kinking,
and mechanical failure were determined at plain radiogra-
phy.
Procedural success. Technical success was successful
vascular access and deployment of the device, absence of
type I or type III endoleak, and a patent endoluminal graft
through the first 24-hour postoperative period. If un-
planned endovascular or surgical procedures were required
to obtain success, it was counted as secondary technical
success. Clinical success defined absence of AAA-related
death, any type I or type III endoleak, postprocedural AAA
enlargement greater than 5 mm in maximum diameter,
greater than 20% endograft dilation, endograft migration,
device failure, aneurysm rupture, or conversion to open
repair.
Because of interstudy and interobserver differences,
aneurysm shrinkage was verified as diameter decrease of 5
mm or greater compared with preoperative values. Sac
enlargement was defined as increase of 5 mm or more in
aneurysm diameter between any two measurements.
Deaths were classified as operative (within 30 days post
surgery), device-related, or procedure-related; or as late,
and either aneurysm-related, due to aneurysm rupture,
primary or secondary procedures, or surgical conversion, or
aneurysm-unrelated.
The study was approved by a Mayo Foundation insti-
tutional review board, and informed written consent was
obtained in all cases.
Statistical analysis. Data are expressed as mean SD,
or total number and percentage. Dichotomous variables
were analyzed with 2 analysis and Fisher exact test. Nu-
meric data were tested for normal distribution with the
1-sample Kolmogorov-Smirnov test and compared with
Mann-Whitney U or Student t test as appropriate. Cumu-
lative survival, time to secondary procedure, and time to
occurrence of endoleak (any type or type II) were estimated
with the Kaplan-Meier method, and Cox proportional haz-
ards models adjusted for gender were used to investigate
the effect of age on the various end points. Baseline demo-
graphic variables were added separately to the above mod-
els to investigate associations between the primary end
points and preoperative differences. No more than 3 vari-
ables were included in a Cox model at one time. P  .05
was considered significant.
RESULTS
A total of 182 patients underwent EVAR between June
1999 and September 2003. Forty-nine patients (26.9%)
were 80 years of age or older at the time of surgery (study
group [SG]), and 133 patients (73.1%) were younger (con-
trol group [CG]). Mean age was 83.6  2.6 years in the
octogenarian group, and 72.24  5.7 years in the control
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octogenarian group, and 18:1 (94.7% male) in the control
group (P  .101). Mean follow-up time was 16.3  12.6
months (range, 0.1-43.3 months).
Demographic data and aneurysm anatomy. Demo-
graphic data and medical comorbid conditions are listed in
Table I. Aneurysm measurements were not statistically
significant between groups (P not significant for all tests),
and overall mean transverse aneurysm diameter was 57.3
8.7 mm (range, 33-84 mm). The suprarenal aortic diame-
ter was wider in the octogenarian group (25.1 2.7 mm vs
24.1 2.5 mm; P .017), and aneurysm neck length (SG
30.7  13.3 mm vs CG 26.5  12.1 mm; P  .063) and
mid-neck diameter (SG 23.1  2.6 mm vs CG 23.4  3.2
mm; P  .669) were comparable.
Hospitalization data and perioperative morbidity.
General anesthesia was used in 92.3% of patients, neuro-
axial blockage in 2.2% of patients, and paravertebral block-
age in 5.5% of patients. No differences were noted in the
type of endograft used (P not significant in all cases).
Operative time (SG 179.4  65.2 minutes vs CG 182.4 
62.8 minutes; P  .779), intraoperative blood loss (SG
470.1 501.55 mL vs CG 470.4 500.8 mL; P .879),
returned autologous blood (cell saver; SG 109.0  196.3
mL vs CG 142.5 295.6 mL; P .779), and homologous
blood transfusion (SG 0.5  1.3 units vs CG 0.2  0.6
units; P  .143) were comparable. One iliac artery lacera-
tion during device introduction (CG) was repaired with an
iliofemoral graft, followed by successful device deployment
through this conduit. Intensive care unit admission was
required in 12 patients (SG 5 vs CG 7; P  .193) for 1
(91.7%) or 2 (8.3%) days.
Table I. Patient demographic data and comorbid conditio
Study grou
Mean
Weight (kg) 76.84
Preoperative creatinine (mg/dL) 1.09
Preoperative ejection fraction (%) 52.29
n
Hypertension 31
Diabetes mellitus 5
Hyperlipidemia 21
Coronary artery disease 32
Carotid artery disease 16
Pulmonary dysfunction 27
Renal insufficiency* 5
Nicotine use, current or former 14
ASA score 4 7
Female
Gender 6
ASA, American Society of Anesthesiologists.
*Serum creatinine concentration 1.5 mg/dL.Postoperative complications occurred more often in
older patients (22.4% vs CG 10.5%; P  .035), owing to a
higher proportion of patients with postoperative rise in
serum creatinine concentration greater than 30% to preop-
erative values (SG 14.9% vs CG 5.3%; P .048). However,
the percentage of patients with absolute serum creatinine
levels 1.5 mg/dL or greater after endografting did not
significantly differ between groups (SG 16.3% vs CG
15.8%; P  .546). Two patients (1%) needed preoperative
and postoperative long-term hemodialysis. Other compli-
cations included myocardial infarction (SG 0 vs CG 2),
pneumonia (SG 1 vs CG 3), transient ischemic attack (SG 1
vs CG 0), and gastrointestinal complications (2 ileus, 1
upper gastrointestinal bleeding, all CG). Total length of
hospital stay was comparable at 4.1  2.2 days for elderly
patients, and 4.0  1.8 days for younger patients (P 
.350). Wound infections, defined by positive wound cul-
ture and requirement for antibiotic treatment, occurred in
1.6% (SG 0.0% vs CG 1.9%; P .107). Groin lymphoceles
developed more frequently in octogenarian patients (SG
12.2% vs CG 2.3%; P  .013).
Postoperative mortality and patient survival. One
operative procedure-related death (0.5%) occurred (loss of
airway in the recovery room), accounting for a 30-day
mortality of 0.5% (SG 0.0% vs CG 0.8%; P  .740).
Patient survival in the octogenarian group was 84.9% at
1 year, 78.3% at 2 years, and 59.8% at 3 years, and for the
control group was 94.4%, 81.9%, and 76.8%, respectively.
The estimated risk for death in octogenarian patients was
1.8 times (95% confidence interval [CI], 0.8-4.0) that in
younger patients (P  .131, long-rank test; Fig 1). Ele-
vated blood lipid levels (relative risk, 1.06; 95% CI, 0.711-
Control group
PD Mean SD
.23 87.77 17.02 .001
.27 1.18 0.63 .957
.49 51.92 12.11 .815
n %
.3 90 67.7 .349
.2 18 13.5 .374
.9 78 58.6 .042
.3 80 60.2 .324
.7 40 30.1 .463
.1 62 46.6 .198
.2 23 17.3 .173
.6 63 47.4 .015
.3 21 15.8 .968
ale Female Male
7 126 .101ns
p
S
15
0
10
%
63
10
42
65
32
55
10
28
14
M
43
Cox
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1.08) did not predict poorer survival in patients older than
80 years.
Aneurysm-related outcome. No aneurysm rupture
occurred. Technical success rate was 97.3% (SG 47 vs CG
130; P  .408), with a primary success rate of 96.7% (SG
95.9% vs CG 97.0%; P .513). Overall clinical success rate
was 89.0% (SG 85.7% vs CG 90.2%; P  .269). Assisted
primary clinical success was achieved in 7.1% (SG 6.1% vs
CG 7.5%). Secondary clinical success (femorofemoral by-
pass for graft limb thrombosis) was obtained in 1 patient
(0.5%, SG). Technical failure occurred in 6 patients (3.3%;
SG 2 vs CG 4; P  .513). This included 1 perioperative
death, partial coverage of the right renal orifice in 1 patient,
and early type I endoleak in 4 patients. Aneurysm-related
Fig 1. Postoperative survival for octogenarian (n 49) v
Bars indicate 95% confidence interval. P corresponds to
Table II. Aneurysm-related and graft-related adverse even
Total
n %
Aneurysm rupture 0 0
1-Year mortality 12 7
30-Day endoleak 22 13
Late endoleak 16 9
Graft migration 7 4
Limb thrombosis 5 3
Graft infection 0 0
NA, Not applicable, no events counted.adverse events are shown in Table II. Of the 7 graft migra-
tions noted, 2 resulted in proximal endoleaks. Five migra-
tions (71.4%) required treatment with placement of addi-
tional proximal extensions (n  4) or conversion to open
repair (n  1). One patient with migration and proximal
endoleak was unfit for further intervention (progressive
renal insufficiency, ejection fraction 17%), and 1 patient
with a long (30 mm) proximal aneurysm neck and adequate
proximal fixation zone is under observation. Of 5 graft limb
occlusions, 40.0% (n  2) required treatment.
Endoleak. Endoleaks of any type and observed at any
time during follow-up were documented in 20.7% of pa-
tients. Of all observed endoleaks, 81.5% were type II, 15.8%
were type I, and 2.6% were type III (P not significant for
differences between groups). The occurrence rate of any
control group patients (n 133) at midterm follow-up.
regression model adjusted for gender.
ring follow- up for all devices
Age (y)
P
80 80
% n %
0 0 0 NA
12 6 5 .068
16 14 10 .206
14 9 7 .101
2 6 4 .394
4 3 2 .408
0 0 0 NAersusts du
n
0
6
8
7
1
2
0
r.
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group was 26.2% at 1 year, 30.0% at 2 years, and 61.7% at 3
years, and 14.4%, 19.9%, and 25.8%, respectively, in the
control group. The estimated risk for occurrence of any
type of endoleak in octogenarians was 2.2 times (95% CI,
1.1-4.2) that in non-octogenarians (P  .023, log-rank
test; Fig 2). For type II endoleaks the estimated relative risk
for octogenarian patients was 2.1 times (95% CI, 1.0-4.3)
higher compared with the control group (P .51, log-rank
test).
Secondary procedures. Secondary procedures were
required in 12.6% of all patients. Time to secondary proce-
dure after endograft implantation was not significantly
different between groups, with the estimated relative risk in
the octogenarian group 1.5 times (95% CI, 0.6-3.6) that in
the control group (P  .420, log-rank test; Fig 3). Three
(2%) patients underwent conversion to open repair (SG 1 vs
CG 2; P .612), 1 after suprarenal aortic rupture proximal
to the successfully treated aneurysm, 1 because of graft
migration after supra-aneurysmal aortic dilatation, and 1
because of endotension. Seven patients (3.8%) required
placement of an additional proximal cuff (3 SG vs 4 CG),
and 7 patients (SG 3 vs CG 4) underwent additional iliac
angioplasty (n  2) or stent placement (n  5). Two graft
limb occlusions were treated with thrombectomy and an-
gioplasty in 1 patient (CG) and with femorofemoral bypass
in the other (SG). Of 8 patients (SG 3 vs CG 5) undergoing
embolization of a persistent type II endoleak, success was
achieved in 6 (75%) patients, whereas 2 complex type II
endoleaks, both in octogenarian patients, persisted despite
several attempts of embolization.
Fig 2. Freedom from any type of endoleak over mid
corresponds to Cox regression model adjusted for gendeAneurysm sac shrinkage. Overall, 97.2% of patients
experienced either stabilization (SG 59.2% vs CG 45.9%) or
decrease (SG 38.8% vs CG 51.1%) in maximum transverse
aneurysm diameter. In the octogenarian group aneurysm
diameter reduction was observed in 32.3% of patients at 1
year, 58.7% at 2 years, and 71.7% at 3 years, and in 47.2%,
74.3%, and 79.5%, respectively, in the control group (P 
.074, log-rank test). Aneurysm enlargement occurred in
2.8% of patients (SG 1 vs CG 4; P  .592).
DISCUSSION
Contemporary operative mortality rates for elective
AAA repair range between 1.2% and 5%, even in the pres-
ence of medical comorbid conditions.10,15-18 However,
surgical series frequently reported higher operative mortal-
ity rates in octogenarian patients (3.6%-8.8%) compared
with younger patients (1.2%-4.3%).4,5,9,10,19,20 In a review
of 800 aneurysm repairs, Cormier et al20 reported a 10%
decreased survival probability at 6 months for octogenari-
ans compared with younger patients after open AAA repair.
EVAR significantly reduces operation and anesthesia times,
blood loss, intensive care unit and total hospital stay, and
major postoperative morbidity associated with open AAA
repair.21,22
Postoperative mortality after EVAR is also low, though
not significantly different from that for open AAA re-
pair.23,24 Previous series found comparable preoperative
comorbid conditions in octogenarian and younger patients
undergoing AAA repair.12 In the present study we found a
higher prevalence of hyperlipidemia and nicotine use in
patients younger than 80 years compared with the older
follow-up. Bars indicate 95% confidence interval. Pterm
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ported previous or current use of nicotine, compared with
less than a third of patients in the octogenarian group. With
caution to a possible selection bias in our octogenarian
cohort, it is recognized that nicotine is potentially one of
the most important risk factors for atherosclerosis and AAA
development. The larger suprarenal aortic diameters in
older patients with aneurysm might also indicate the possi-
bility of different processes of aneurysm formation between
groups. These findings have not been reported before,
probably because the advent of endovascular treatment
mandated a more standardized approach to aortoiliac mea-
surements compared with older open surgical series. On-
going dilation of the proximal aortic segment after EVAR
is, however, well recognized, and has been reported as 0%25
to 15.5%26 of the preoperative diameter 2 years after the
intervention. Most studies indicate a rather constant diam-
eter increase of 1 to 1.5 mm per year26,27 after EVAR,
whereas others suggest that proximal aortic neck dilatation
may occur only with a prevalence of 15% to 28% in defined
subgroups of patients after EVAR.28,29 While we did not
quantify proximal aneurysm neck diameters postoperatively
in this retrospective study, we did not observe differences in
the use of devices allowing for larger proximal necks (Tal-
ent, IDE) or postoperative endograft migration rates be-
tween study groups. Suprarenal aortic dilation was ob-
served only in 1 control group patient, and did not involve
the proximal infrarenal aorta.
In contrast to previous studies comparing open AAA
repair in octogenarians versus younger patients,9,10,19 we
Fig 3. Freedom from secondary procedures (all aneury
after initial endovascular repair). Bars indicate 95% confid
for gender.did not observe any statistical differences in operative pa-
rameters or in intensive care unit stay between groups. A
higher percentage of lymphoceles in the octogenarian
group did not translate to a higher rate of groin infections
(1.6% overall), nor did it prolong the total length of hospi-
tal stay. The most common postoperative complication was
renal impairment. While both groups had comparable rates
of elevated serum creatinine preoperatively and postopera-
tively, a temporary rise in serum creatinine concentration of
more than 30% compared with baseline was significantly
more common (14% vs 5% in control group) in older
patients, and translated to a higher overall complication
rate in octogenarians. However, the higher rate of tempo-
rary rise in serum creatinine concentration was not associ-
ated with more patients requiring hemodialysis after
EVAR, nor did it prolong hospitalization time or decrease
survival. Increased serum creatinine concentration may be
found in as many as 25% of patients (in the presence of
preexisting renal function impairment) undergoing
EVAR.30 Contrast material–induced nephropathy has been
characterized as the most common cause for such postop-
erative decrease in renal function; other less common con-
tributing factors include thromboembolism of aortic debris
during deployment31 or inadvertent compromise of renal
blood flow from overstenting of the ostium of accessory or
main renal arteries (0.5% in our series).
We did not observe significant differences in technical
and clinical success rates between the 2 groups, and the
success rates in the octogenarian cohort compare favorably
with previously reported results,13 probably related to the
lated endovascular interventions or surgical procedures
interval. P corresponds to Cox regression model adjustedsm-re
ence
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were used in our cohort). In the present study, type II
endoleak developed in 24% of the octogenarian patients,
compared with 14% of younger patients. The risk for de-
velopment of any type of endoleak or a type II endoleak
during follow-up was elevated in elderly patients owing to a
14% incidence of late endoleak in this group (vs 7% in the
CG). Nevertheless, the higher rates of endoleak occurrence
did not decrease postoperative survival or increase the risk
for aneurysm sac enlargement, aneurysm rupture, or sec-
ondary interventions in the octogenarian cohort. A recent
study analyzing 3595 patients after EVAR reported occur-
rence of type II endoleak as positively associated with
increased age, preoperative patency of the inferior mesen-
teric artery, and proximal aneurysm neck length, but neg-
atively correlated with ongoing use of nicotine and low
ankle-arm indices.32 While no biologic basis is known for
the correlation with age alone, the lower rate of type II
endoleak in patients using nicotine was discussed by van
Marrewijk et al32 as related to possibly more severe athero-
sclerosis of aortic side branch vessels, in association with
changes in coagulation profile in smokers.33 In the absence
of aneurysm sac diameter increase, conservative treatment
of type II endoleak is considered safe,34 and the overall
aneurysm sac stabilization or shrinkage rate in this series
(97.2%) corroborates this approach. Five patients had an-
eurysm enlargement during follow-up, and while this was
related to occurrence of endoleak in 3 patients, 2 control
group patients experienced endotension without an appre-
ciable endoleak. Overall, significant decrease in aneurysm
sac diameter after EVAR has been described in octogenar-
ian patients,13 but in the absence of endoleak the actual
postoperative aneurysm shrinkage rate is highly device-
dependent.35 While we noted a trend towards more aneu-
rysm sac stabilization and less aneurysm sac shrinkage in the
octogenarian cohort compared with the control group, the
use of 6 different devices withholds meaningful analyses of
age-specific effects on aneurysm remodeling in this retro-
spective study. Also, these findings did not affect the pri-
mary study end points of postoperative survival or repeat
intervention rate. Further limitations to this study include
the comparable comorbidity profile between groups, which
may indicate selection bias in favor of the octogenarian
group. This may withhold implications regarding true op-
erative risk in the general octogenarian population. In
addition, the number of octogenarians included in this
study yields the possibility of a type II error in some of our
analyses.
In conclusion, elective EVAR seems safe and effective
in patients older than 80 years over midterm follow-up.
With the exception of a temporary decrease in postopera-
tive renal function and more postoperative groin lympho-
celes, advanced chronologic age was not associated with
poorer technical or clinical outcome or postoperative sur-
vival. Age alone should not preclude patients from being
offered endovascular aneurysm repair. In our opinion, be-
cause of low perioperative mortality and high procedural
success, EVAR may be the preferred approach to AAArepair for properly, upon anatomic criteria–selected octo-
genarian patients. Longer follow-up will be necessary to
determine the relevance of the observed higher incidence of
late type II endoleak in elderly patients after EVAR.
We thank Michael Heckmann, MS, for valuable help
with statistical analysis of the data presented.
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